AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

White T-shirts get a lot of attention, but let’s not forget their equally versatile counterpart: the exceedingly wearable, deceptively simple black T-shirt. It’s a staple you can wear to work ...

Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections. The drug – a combination of beta-lactam antibiotic aztreonam with beta ...

Here are the top phones from Apple, Google, Samsung and others that we've tested for T-Mobile, including those you need to access the fastest network speeds. I’m one of PCMag’s mobile analysts ...

US stock futures held steady after markets breathed a sigh of relief thanks to a cooler-than-expected inflation report that buoyed tech shares in day trading. Intel (INTC) is in focus after naming ...

After hours: March 13 at 7:59:52 PM EDT Loading Chart for T ...

Competing Interests: The author has been involved in clinical trials of albendazole and nitazoxanide, and has received research funding for these trials from SmithKline Beecham Pharmaceuticals and ...

Pre-market: 8:01:29 am GMT-4 Loading Chart for ABBV ...

* Between subway hours and Owl service, use the T Bus. See below for detailed schedule information and live data.

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce the risk of stroke and deep vein thrombosis.